Table 5.

Demographics and neurocognitive characterization for participants enrolled in the supplemental clinical imaging sample

	Children
	Controls	Deletion carriers	Duplication carriers
n	21 (0)	28 (14)	16 (0)
Mean age ±SD	8.1 ± 3	9.9 ± 4	7.8 ± 5
Range	1–15	1–16	1–16
Male:female	8:13	17:11	10:6
L:R:ambi:Unk	1:16:2:2	4:17:5:2	2:8:1:5
FSIQ	106 ± 10	86 ± 15	78 ± 12
NVIQ	104 ± 9	90 ± 14	79 ± 16
Range (NVIQ)	89–120	64–130	57–114
SRS, ≥60	20 ± 20 , 1/20	78 ± 40 , 17/25	81 ± 39 , 9/12
Vineland II, ≤85	103 ± 11 , 1/21	78 ± 11 , 23/28	78 ± 12 , 12/16
SCQ, ≥15	2 ± 2 , 0/20	11 ± 9 , 8/25	14 ± 7 , 5/11
ADI	0/1	10/20	8/11
ADOS	0/21	8/28	3/16

Abbreviations as described in Table 1. The number in parenthesis denotes how many participants from the main analysis of the neuroimaging protocol overlapped with the clinically acquired MRI scans included in the secondary analysis. The controls and duplication carriers were unique, but half of the deletion carriers overlapped between the two sets of analyses.